Veea Systems (VEEA) Stock Soars 90% on NovaGen Merger News

Key Takeaways

• Shares of Veea Systems skyrocketed nearly 90% on Tuesday following the announcement of a merger term sheet with NovaGen Group B.V.
• The newly formed entity will operate as NovaGen Health Networks, combining edge AI technology with healthcare data infrastructure for regenerative medicine applications.
• A $10 million investment commitment from GeoNova Capital has been secured through a signed term sheet for the merged company.
• The merger partners estimate the combined organization’s value at roughly $750 million, derived from internal projections and external valuation analysis.
• Share volume skyrocketed beyond 41 million units, dramatically exceeding the typical three-month average of approximately 150,000 shares per session.

Veea Systems shares climbed more than 172% to reach $6.23 on Tuesday, building on Monday’s impressive 46.79% advance. The rally was triggered by the edge-computing firm’s disclosure of merger plans with NovaGen Group B.V., a transaction designed to establish a connected healthcare technology platform.

Veea Inc., VEEA

Both organizations have executed a term sheet with expectations to complete definitive agreements in the coming weeks.

Operating under the NovaGen Health Networks banner, the merged organization will integrate Veea’s edge-computing capabilities, cybersecurity infrastructure, and artificial intelligence systems with NovaGen’s regenerative medicine software solutions.

Built on Veea’s VeeaONE infrastructure, the system will aggregate medical records, wearable device data, sensor information, and biometric measurements into unified, long-term health profiles managed and stored on edge devices.

Control over data access will remain with individual patients—a central feature the companies are emphasizing in their value proposition.

Deployment is scheduled to begin at NovaGen treatment facilities and affiliated medical centers during the fourth quarter of 2026. Early rollout efforts will concentrate on AI-powered health applications and medical record integration.

GeoNova Capital Signs $10 Million Investment Agreement

GeoNova Capital has executed a term sheet as the primary investor, committing $10 million to the merged organization to support commercial expansion efforts.

The merger partners assessed the combined company’s valuation at approximately $750 million, drawing from strategic business plans and independent valuation assessments. Both the merger transaction and GeoNova’s capital commitment remain subject to final documentation.

Veea CEO Allen Salmasi emphasized that the architecture positions artificial intelligence and data processing capabilities at the point of care delivery, while strengthening patient ownership of personal medical data.

NovaGen CEO Diederik van der Reijt highlighted that the network establishes a mechanism to identify and assess potential therapy candidates, potentially initiating patient engagement prior to clinical visits.

Trading Activity Surges Dramatically

The stock’s Tuesday performance generated extraordinary market activity. VEEA recorded more than 41 million traded shares, vastly surpassing the three-month daily average of approximately 150,000 shares.

This represents approximately 270 times typical daily trading volume.

Notwithstanding Tuesday’s dramatic gains, the stock remains down 82.03% year-to-date and has declined 79.13% across the trailing twelve-month period.

Analyst coverage of Veea remains sparse. TipRanks’ Overall Consensus indicates a Neutral stance, reflecting eight Bearish signals, six Neutral readings, and eight Bullish technical indicators.

Management has indicated that Veea will maintain operations serving its current client base and market segments in parallel with the new healthcare venture.

The post Veea Systems (VEEA) Stock Soars 90% on NovaGen Merger News appeared first on Blockonomi.